Market revenue in 2023 | USD 19.5 million |
Market revenue in 2030 | USD 36.1 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Kuwait mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
The country’s need for mRNA therapeutics services is rising due to the growing product pipeline and increasing R&D expenditure, propelling the mRNA therapeutics CDMO market. Kuwait’s existing research unit is likely to further boost market growth.
In addition, the country’s increasing prevalence of diseases is creating a high demand for vaccines and fueling market growth. The rising number of companies entering the market, collaborating with others, and innovating vaccines in the country can further drive the market. Such factors are expected to promote the R&D of mRNA therapeutics, supporting the CDMO market in Kuwait.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account